These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120. Chiba H, Inokoshi J, Nakashima H, Omura S, Tanaka H. Biochem Biophys Res Commun; 2004 Mar 26; 316(1):203-10. PubMed ID: 15003531 [Abstract] [Full Text] [Related]
33. Transgenic plant production of Cyanovirin-N, an HIV microbicide. Sexton A, Drake PM, Mahmood N, Harman SJ, Shattock RJ, Ma JK. FASEB J; 2006 Feb 26; 20(2):356-8. PubMed ID: 16354721 [Abstract] [Full Text] [Related]
35. Isolation and characterization of anti-HIV peptides from Dorstenia contrajerva and Treculia obovoidea. Bokesch HR, Charan RD, Meragelman KM, Beutler JA, Gardella R, O'Keefe BR, McKee TC, McMahon JB. FEBS Lett; 2004 Jun 04; 567(2-3):287-90. PubMed ID: 15178338 [Abstract] [Full Text] [Related]
36. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120. Gopi HN, Tirupula KC, Baxter S, Ajith S, Chaiken IM. ChemMedChem; 2006 Jan 04; 1(1):54-7. PubMed ID: 16892335 [No Abstract] [Full Text] [Related]
37. The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches. Woodrum BW, Maxwell JD, Bolia A, Ozkan SB, Ghirlanda G. Biochem Soc Trans; 2013 Oct 04; 41(5):1170-6. PubMed ID: 24059504 [Abstract] [Full Text] [Related]
38. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention. Auwerx J, François KO, Covens K, Van Laethem K, Balzarini J. Virology; 2008 Dec 05; 382(1):10-9. PubMed ID: 18930512 [Abstract] [Full Text] [Related]
39. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. Balzarini J, Van Laethem K, Peumans WJ, Van Damme EJ, Bolmstedt A, Gago F, Schols D. J Virol; 2006 Sep 05; 80(17):8411-21. PubMed ID: 16912292 [Abstract] [Full Text] [Related]